Nutrition, health and beauty innovator nclick="updateothersitehits('Articlepage','External','OtherSitelink','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','338977','https://www.foodingredientsfirst.com/profile-directory/dsm-firmenich.html', 'article','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US');return no_reload();">dsm-firmenich won its patent defense of its proprietary docosahexaenoic acid (DHA) oils following an inter partes review and cancellation request by Mara Renewables Corporation.

The United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) rejected the premise of the invalidation action on US Patent No 10,392,578, which protects specific dsm-firmenich innovations in providing nutritional lipids rich in DHA omega-3 derived from algal sources.

“Although we were confident from the outset, we are nonetheless pleased with the PTAB’s decision to uphold our patent. This outcome validates our significant investments in and commitment to innovation and underscores our position as a technology leader,” says James Young, vice president of Early Life Nutrition at dsm-firmenich.

Gloves off for microbial lipids
The PTAB’s refusal to review the patent’s validity allows dsm-firmenich to retain its exclusive rights in the US to its microbial lipid compositions with DHA triglyceride fractions of 40 weight percentage or higher.

The PTAB concluded that “there was no reasonable likelihood that petitioner Mara Renewables would prevail in successfully invalidating a claim of the challenged patent.”

The decision reinforces the validity of dsm-firmenich’s patent in the US and builds on favorable decisions and opinions taken by the European Patent Office recently about related patents claiming similar technology in Europe.

Innovation status
In late 2023, dsm-firmenich launchednclick="updateothersitehits('Articlepage','External','OtherSitelink','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','338977','https://www.foodingredientsfirst.com/news/dsm-firmenich-unveils-starter-cultures-for-mild-yogurt-with-long-lasting-ph-stability.html', 'article','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US');return no_reload();"> a new generation of starter cultures for very mild yogurts. Its new product, DelvoFresh Pioneer, enables improved pH stability during processing and throughout shelf life, ensuring consistent mildness and indulgence for consumers, with cold storage of up to 60 days.

The company presented its nclick="updateothersitehits('Articlepage','External','OtherSitelink','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','338977','https://www.nutritioninsight.com/news/dsm-firmenich-to-illuminate-postbiotics-and-proactive-health-at-supplyside-west.html', 'article','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US');return no_reload();">latest strides in gut support, women’s wellness and cognitive performance innovations at Supplyside West in Las Vegas, US, 2023, coined “bringing progress to life.”

In addition, nclick="updateothersitehits('Articlepage','External','OtherSitelink','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US','338977','https://www.foodingredientsfirst.com/news/hmos-for-life-dsm-firmenich-discusses-the-importance-and-potential-of-hmos-for-human-health.html', 'article','dsm-firmenich successfully defends patent directed to proprietary DHA oils in US');return no_reload();">human milk oligosaccharides (HMOs) as an ingredient in baby and toddler products saw a remarkable increase from 2018 to 2022. The majority of these launches consisted of baby formula and milk. We spoke with James Young, the vice president of early life nutrition at dsm-firmenich, about the upcoming developments in the HMO space, the company’s vision for the ingredient’s future and what makes HMOs important.